"With the honorary doctorate of the University of Vienna, Emmanuelle Charpentier receives a highly deserved award from the ...

Researchers at Duke University and North Carolina State University have discovered a handful of new CRISPR-Cas systems that ...

The EU is to set to release a new class of genetically modified crops from strict regulation that dates back over 20 years, ...

Currently, these technologies are subject to the EU’s strict GMO regulation, making their commercialisation in the bloc ...

A genetic breakthrough may soon bring bigger and better tomatoes and eggplants to the world. Scientists have mapped the ...

Gene editing, particularly CRISPR/Cas9-based systems, provides a more precise and efficient alternative. CRISPR/Cas9 allows ...

Researchers from Tel Aviv University utilized CRISPR to cut a single gene from cancer cells of head and neck tumors—and ...

Casgevy (exagamglogene autotemcel or exa-cel) became the first drug based on the CRISPR/Cas9 gene-editing technology ... which earned its discoverers a Nobel Prize in 2020. The one-shot therapy ...

When Vijay Sankaran was an MD-PhD student at Harvard Medical School in the mid-2000s, one of his first clinical encounters ...

Learn how CASGEVY, the first NHS-approved CRISPR gene therapy, treats sickle cell disease through a revolutionary genetic ...

In 2012, Jennifer Doudna and Emmanuelle Charpentier published their groundbreaking work, revealing that CRISPR/Cas9 could be re-engineered as a gene-editing tool. They won the Nobel Prize in ...

is the first licensed therapy to utilise CRISPR/Cas9 gene-editing technology, whose inventors were awarded the 2020 Nobel Prize in Chemistry. The therapy offers a potential functional cure for SCD ...